Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 12INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Gynecologic 1

Conditions

Neoplasms 9Carcinoma, Non-Small-Cell Lung 7Colorectal Neoplasms 6Breast Neoplasms 6Prostatic Neoplasms 5Papillomavirus Infections 5Ovarian Neoplasms 4Neoplastic Cells, Circulating 4Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 3Lung Neoplasms 3Melanoma 2Lymphoma, Follicular 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Carcinoma, Hepatocellular 2Thymic aplasia 1Stomach Neoplasms 1Solid Tumor, Adult 1Small Cell Lung Carcinoma 1Respiratory Distress Syndrome 1Recurrence 1Rectal Neoplasms 1Radiation Injuries 1Pulmonary Disease, Chronic Obstructive 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pancreatic Neoplasms 1Osteosarcoma 1Opioid-Related Disorders 1

Interventions

Cytarabine 21Imatinib Mesylate 20venetoclax 16Azacitidine 16nilotinib 15Cyclophosphamide 15fludarabine 13Dasatinib 12blinatumomab 10Rituximab 10quizartinib 7Gemtuzumab 7Daunorubicin 7ruxolitinib 6Drug Therapy 6Clofarabine 6Bendamustine Hydrochloride 6AP 1903 reagent 6ponatinib 5fludarabine phosphate 5Whole-Body Irradiation 5Vincristine 5Mycophenolic Acid 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Dexamethasone 5vosaroxin 4revumenib 4rasburicase 4forodesine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Leukemia × Blood Specimen Collection × Clear all
NCT02016833 2015-04-30

Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

PX Biosolutions

Completed
15 enrolled
GynecologicMyeloidOther hematologic neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Leukemia, Ovarian Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡